December 2021 updates to the website
16 December 2021
The website has now been updated following November's LSCMMG
The following guidelines have been added/updated:
Overactive bladder guidance - New (Agreed, However awaiting further information prior to publishing)
Dapagliflozin for T1 DM – TA 597 - Withdrawn and removed from the website
The following Items will be updated and added to the website following the next Strategic Commissioning Committee (SCC) Meeting:
Glycopyrronium - Hypersalivation in patients with Non - Parkinson's Disease
Upadacitinib - Upadacitinib for treating moderate rheumatoid arthritis (NICE TA744)